BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

PTEN mRNA nanoparticles increase sensitivity to cancer immunotherapy

By Claire Quang, Staff Writer
July 29, 2021 10:40 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Melanoma; prostate cancer...

BCIQ Company Profiles

Brigham and Women's Hospital

Harvard Medical School

National Center for Nanoscience and Technology

Sun Yat-sen University

BCIQ Target Profiles

Phosphatase and tensin homolog deleted on chromosome ten (PTEN) (MMAC1) (TEP1)

BCIQ Company Profiles

Brigham and Women's Hospital

Harvard Medical School

National Center for Nanoscience and Technology

Sun Yat-sen University

BCIQ Target Profiles

Phosphatase and tensin homolog deleted on chromosome ten (PTEN) (MMAC1) (TEP1)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS